Applied Filters:
Keyword:'111-65-9'
Language
Topic
Content Type
Collections
Topic Area
Applications
Product Category
111-65-9
Showing 1-10 of 586 results for "111-65-9" within Site Content
Efficient dye-sensitized solar cells for direct conversion of sunlight to electricity
Dye-sensitized solar cells directly convert sunlight to electricity
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion
MilliporeSigma today announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin.
Poly(2-Oxazoline)s: The Versatile Polymer Platform for Biomedicine
The introduction of polymers into the biomedical field has opened new avenues in tissue engineering, implant design, biosensing, and drug delivery.
X-tremeGENE™ 9 DNA Transfection Reagent Protocol
Plate cells approx. 24 hours before transfection making sure cells are at optimal concentration (70 – 90 % confluency).
CRISPR Cas 9 Nuclease RNA-guided Genome Editing
Learn about CRISPR Cas9, what it is and how it works. CRISPR is a new, affordable genome editing tool enabling access to genome editing for all.
Color Determination of sugar based on ICUMSA Color GS2-9
Learn about the ICUMSA® Method GS2-9 (2024) to measure the color of sample solutions of white sugar or highly pure sugar syrup of color index up to 600 IU.
Synthesis of Melting Gels Using Mono-Substituted and Di-Substituted Alkoxysiloxanes
Synthesis of Melting Gels Using Mono-Substituted and Di-Substituted Alkoxysiloxanes
Carcinogenesis and Epigenetics
Cancer research has revealed that the classical model of carcinogenesis, a three step process consisting of initiation, promotion, and progression, is not complete.
MilliporeSigma Expands in Gillingham, UK, Boosts Distribution Capabilities
MilliporeSigma today announced the completion of a £9 million expansion to its Gillingham distribution center.
Accelerated mAb Development Program – From Transfection to GMP Drug Substance in 9 Months
The accelerated mAb development program delivers GMP drug substance nine months from transfection. We designed the mAbExpress™ program to be fast, cost effective, and appropriate for the early clinical phase of your program, with regulatory support throughout.
Page 1 of 59